President and CEO

Vice President, Global Pricing and Market Access

REGENXBIO Announces Presentation at the World Muscle Society

Diabetic Retinopathy Market to Reach USD 17.82 Billion by 2034 as Diabetes Cases and Aging Population Rise

REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE® Trial of RGX-121 for Treatment of MPS II

Regenxbio reports 'positive' results from Phase I/II/III CAMPSIITE trial

Contract Clinical Trial Trainer

REGENXBIO is an exceptional place where some of the best and brightest people have the opportunity to collaborate and contribute toward extraordinary plans. As a Contract Clinical Trial Trainer, you will assist in delivering clinical trial related curriculum modules and training plans, ensuring compliance with ICH/GCP guidelines and Federal Regulations. You will also support the monitoring of clinical trial training compliance through the Learning Management System.

Sign up with Google

Sign in with Google